This article is a correction to:
Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction
Liyun Zhang
Juan Chen- Department of Cardiology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
A Corrigendum on
Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction
by Zhang, L., Chen, J., Yan, L., He, Q., Xie, H., and Chen, M. (2021). Front. Pharmacol. 12:646240. doi: 10.3389/fphar.2021.646240
In the original article, there were two errors. The Wuhan Central Hospital’s animal experiment center was not involved in providing the animals nor in approving experimental procedures, but rather the animal experiment center of Tongji Medical College, Huazhong University of Science and Technology.
A correction has been made to Materials and Methods, “Animals,” paragraph 1. The corrected paragraph appears below:
“Male C57BL/6 mice (8- to 10-week-old) were supplied by the animal experiment center of Tongji Medical College, Huazhong University of Science and Technology. Mice were allowed 1 week to acclimatize to a stable environment before experiments began. Mice were individually housed in plastic cages with bedding, ad libitum food, and tap water. The cages were maintained at a temperature of 22 ± 2°C and a 12:12 h light/dark cycle. Mice were randomly assigned to four groups: sham with vehicle (sham-vehicle), sham with RES (sham-RES), HFpEF with vehicle (HFpEF-vehicle), and HFpEF with RES (HFpEFRES). All mice underwent uninephrectomy and received a continuous infusion of either saline (sham) or d-aldosterone (0.15 mg/h) (HFpEF) for 4 weeks via osmotic mini-pumps (Alzet, Durect Corp., Cupertino, CA, United States) (Tanaka et al., 2014). Twenty-4 hours after the surgery, mice were administered RES (10 mg/kg/day) by oral gavage for the duration of 4 weeks (Gupta et al., 2014) (Figure 1B). All experimental procedures were according to the Guidelines for the Care and Use of Laboratory Animals published by the United States National Institutes of Health and were approved by the Animal Care and Use Committee of Tongji Medical College, Huazhong University of Science and Technology (Approval Number: 20191808).”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: resveratrol, heart failure with preserved ejection fraction, inflammation, macrophage polarization, oxidative stress
Citation: Zhang L, Chen J, Yan L, He Q, Xie H and Chen M (2022) Corrigendum: Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction. Front. Pharmacol. 13:857367. doi: 10.3389/fphar.2022.857367
Received: 18 January 2022; Accepted: 22 February 2022;
Published: 18 March 2022.
Edited and reviewed by:
Chrishan S. Samuel, Monash University, AustraliaCopyright © 2022 Zhang, Chen, Yan, He, Xie and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Manhua Chen, chenmh0918@163.com